Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Wiley Handbook of Current and Emerging Drug Therapies, Volumes 5 - 8 -  Wiley Technology

Wiley Handbook of Current and Emerging Drug Therapies, Volumes 5 - 8

Buch | Hardcover
3120 Seiten
2007
Wiley-Interscience (Verlag)
978-0-470-04099-7 (ISBN)
CHF 2.479,95 inkl. MwSt
  • Titel z.Zt. nicht lieferbar
  • Portofrei ab CHF 40
  • Auch auf Rechnung
  • Artikel merken
A comprehensive resource for drug discovery and pharmaceutical research The Wiley Handbook of Current and Emerging Drug Therapies brings together, for the first time in a single resource, the most current information on drug discovery and pharmaceutical research.
AT LAST - a comprehensive, authoritative resource customized for biomedical, pharmaceutical and drug discovery research! Easy-to-access information on currently available drugs, plus the status of drug development and approval, for every major therapeutic area!

Here is an all-encompassing reference tailored to the needs of research managers, chemists and biologists, clinical scientists, and executives in the pharmacology and biotechnology industry.  No other resource focuses on drug discovery and pharmaceutical research from this unique perspective combining scientific and business aspects of today's biotechnology.

Within every major therapeutic area, the Wiley Handbook of Current and Emerging Drug Therapies provides a general overview of the etiology and pathophsiology of the important disease indications.  Then, you'll find a comprehensive analysis of currently approved drugs targeting these diseases, with information on mechanism of action, efficacy, side effects and future prospects.  You'll also find product-by-product analyses of drugs currently in development, including mechanism of action, formulations, and detailed information on the status of clinical trials.

Also available in a regularly-updating online version.  Visit www.interscience.wiley.com/mrw/cedt for more information.

The Handbook's content has been prepared by independent pharmaceutical market research consultants. The authorship will, however, be presented as "Wiley". Wiley empowers learners, researchers, universities, and corporations to achieve their goals in an ever-changing world. For over 200 years, Wiley has been helping people and organizations develop the skills and knowledge they need to succeed. Wiley develops digital education, learning, assessment, and certification solutions to help universities, businesses, and individuals move between education and employment and achieve their ambitions. By partnering with learned societies, we support researchers to communicate discoveries that make a difference. Our online scientific, technical, medical, and scholarly journals, books, and other digital content build on a 200-year heritage of quality publishing.

Vol. 1. Part I: Introduction Part II: Oncology

Vol. 2. Part II: Oncology

Part III: Immune system

Vol. 3. Part IV: Metabolic diseases

Part V: Infectious diseases

Vol. 4. Part VI: Emerging technologies and business opportunities

Part VII: Global markets and national policy

Part VIII: New opportunities in drug discovery and pipeline development

Vol. 5. Part IX: Metabolic diseases

Part X: Infectious diseases

Part XI: Central nervous system

Vol. 6. Part XI: Central nervous system

Part XII: Ophthalmologic

Part XIII: Cardiology

Vol. 7. Part XIII: Cardiology

Part XIV: Genitourinary

Part XV: Pain treatment

Part XVI: Respiratory

Part XVII: Gastrointestinal

Part XVIII: Major issues in pharmaceutical R & D

Part XIX: Global markets and national policy

Part XX: Technological advances and business opportunities

Reihe/Serie Wiley Handbook of Current and Emerging Drug Therapies. 4 Volume Set | 1.20
Sprache englisch
Maße 183 x 254 mm
Gewicht 5225 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
ISBN-10 0-470-04099-8 / 0470040998
ISBN-13 978-0-470-04099-7 / 9780470040997
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich